Functional Effects of Toll-like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 Stimulation in Nasal Epithelial Cells
Overview
Authors
Affiliations
Background: The human nasal epithelium is an important physical barrier, and a part of the innate immune defense that protect against pathogens. The epithelial cells recognize microbial components by pattern-recognition receptors (PRRs), and thereby trigger an immune response. Even though TLR3, TLR7, TLR9, RIG-I and MDA-5 are all known to respond to viral stimulation, their potential role in chronic airway inflammation triggered by local cytokine release remains to be established.
Methods: mRNA and corresponding protein expression of TLR3, TLR7, TLR9, RIG-I and MDA-5 were analyzed in nasal biopsies and various upper airway epithelial cell lines using real-time reverse transcription PCR, immunohistochemistry and flow cytometry. Ligand induced, cytokine release, was evaluated with ELISA.
Results: Nasal biopsies were found to express TLR3, TLR7, TLR9, RIG-I and MDA-5, with the most abundant expression in the surface epithelium. These receptors were verified in primary human nasal epithelial cell (HNEC) as well as in the airway epithelial cell lines Detroit-562 and FaDu. Poly(I:C) (TLR3) and R-837 (TLR7) stimulation increased secretion of IL-6 and GM-CSF from the nasal mucosa and the epithelial cell lines. CpG (TLR9) stimulation caused release of IL-8 in the nasal mucosa and in FaDu. Poly(I:C)/LyoVec (RIG-I/MDA-5) stimulation activated the secretion of IFN-β in the nasal mucosa. A corresponding release was also detected from HNEC and Detroit-562.
Conclusion: The nasal epithelium has the ability to recognize viral intrusion through TLR and RLR receptors, and the subsequent response might have a role in exacerbation of inflammatory diseases like allergic rhinitis and chronic rhinosinusitis.
Toll-like receptor 3: a double-edged sword.
Hsieh M, Nishizaki D, Adashek J, Kato S, Kurzrock R Biomark Res. 2025; 13(1):32.
PMID: 39988665 PMC: 11849352. DOI: 10.1186/s40364-025-00739-5.
da Silva Barcelos L, Ford A, Fruhauf M, Botton N, Fischer G, Maggioli M Viruses. 2024; 16(11).
PMID: 39599867 PMC: 11598946. DOI: 10.3390/v16111753.
Seefeld M, Templeton E, Lehtinen J, Sinclair N, Yadav D, Hartwell B Front Immunol. 2024; 15:1419527.
PMID: 39286244 PMC: 11403286. DOI: 10.3389/fimmu.2024.1419527.
Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID.
Pacheco-Garcia U, Varela-Lopez E, Serafin-Lopez J Int J Mol Sci. 2024; 25(14).
PMID: 39062904 PMC: 11277483. DOI: 10.3390/ijms25147661.
Transcriptional control of metabolism by interferon regulatory factors.
Ahmad Z, Kahloan W, Rosen E Nat Rev Endocrinol. 2024; 20(10):573-587.
PMID: 38769435 PMC: 11392651. DOI: 10.1038/s41574-024-00990-0.